Role of HLA-G in maternal–fetal immune tolerance
- 1 February 1999
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 31 (1-2) , 724-725
- https://doi.org/10.1016/s0041-1345(98)01622-4
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamilyEuropean Journal of Immunology, 1998
- HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2AProceedings of the National Academy of Sciences, 1998
- Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysisProceedings of the National Academy of Sciences, 1997
- The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.The Journal of Immunology, 1997
- The α1domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?Proceedings of the National Academy of Sciences, 1997
- Expression of killer cell inhibitory receptors on human uterine natural killer cellsEuropean Journal of Immunology, 1997
- Human Histocompatibility Leukocyte Antigen (HLA)-G Molecules Inhibit NKAT3 Expressing Natural Killer CellsThe Journal of Experimental Medicine, 1997
- Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target CellsScience, 1996
- Resistance of HLA-G and HLA-A2 Transfectants to Lysis by Decidual NK CellsCellular Immunology, 1994